Instituto de Investigación, Innovación y Tecnología Educativas (UNIR iTED)
Facultad
University of Bordeaux
Burdeos, FranciaPublications in collaboration with researchers from University of Bordeaux (8)
2020
-
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 628-639
2016
-
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1056-1062
-
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy
HIV Medicine, Vol. 17, Núm. 6, pp. 471-478
2015
2014
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2013
-
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study
BMC Infectious Diseases, Vol. 13, Núm. 1
2011
-
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naïve HIV-2-infected patients: The ACHIEV2E collaboration study group
Clinical Infectious Diseases, Vol. 52, Núm. 10, pp. 1257-1266
2008
-
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies
AIDS, Vol. 22, Núm. 16, pp. 2143-2153